Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer

Saw, Stephanie P. L. and Zhong, Wen-Zhao and Fu, Rui and Li, Molly S. C. and Goto, Yasushi and Fox, Stephen B. and Yatabe, Yasushi and Ong, Boon-Hean and Ng, Calvin S. H. and Lee, David D. W. and Phuong, Pham Cam and Park, In Kyu and Yang, James C. H. and Tsuboi, Masahiro and Tho, Lye Mun and John, Thomas and Hsu, Hsao-Hsun and Tan, Daniel S. W. and Mok, Tony S. K. and Reungwetwattana, Thanyanan and Singh, Navneet (2025) Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer. Lung Cancer, 200. p. 108076. ISSN 0169-5002, DOI https://doi.org/10.1016/j.lungcan.2024.108076.

Full text not available from this repository.
Official URL: https://doi.org/10.1016/j.lungcan.2024.108076

Abstract

The peri-operative management of non-small cell lung cancer (NSCLC) in earlier stage disease has seen significant advances in recent years with the incorporation of immune checkpoint inhibitors and targeted therapy. However, many unanswered questions and challenges remain, including the application of clinical trial data to routine clinical practice. Recognising the unique demographic profile of Asian patients with NSCLC and heterogeneous healthcare systems, the Asian Thoracic Oncology Research Group (ATORG) convened a consensus meeting in Singapore on 26 April 2024 to discuss relevant issues spanning diagnostic testing to post-neoadjuvant treatment considerations and future directions. An interdisciplinary group of 19 experts comprising medical oncologists, thoracic surgeons, radiation oncologists, pulmonologists and pathologists from Singapore, Hong Kong, Mainland China, Korea, Japan, Taiwan, India, Malaysia, Thailand, Vietnam and Australia met to discuss emerging data, identify existing gaps in clinical care and develop a multidisciplinary, multinational expert consensus statement on the peri-operative management of NSCLC tailored to the Asia-Pacific region.

Item Type: Article
Funders: AstraZeneca
Uncontrolled Keywords: Asian; Consensus statement; Peri-operative; NSCLC
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: Faculty of Medicine > Clinical Oncology Department
Depositing User: Ms. Juhaida Abd Rahim
Date Deposited: 13 Mar 2025 07:41
Last Modified: 14 Mar 2025 01:01
URI: http://eprints.um.edu.my/id/eprint/47721

Actions (login required)

View Item View Item